These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 24999473)
1. The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment. Othman N; Nagoor NH Biomed Res Int; 2014; 2014():318030. PubMed ID: 24999473 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer. Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304 [TBL] [Abstract][Full Text] [Related]
3. The role of microRNAs in lung cancer progression. Zhang WC; Liu J; Xu X; Wang G Med Oncol; 2013; 30(3):675. PubMed ID: 23925663 [TBL] [Abstract][Full Text] [Related]
4. microRNA and Lung Cancer. Del Vescovo V; Denti MA Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001 [TBL] [Abstract][Full Text] [Related]
5. The roles of microRNA in cancer and apoptosis. Lynam-Lennon N; Maher SG; Reynolds JV Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Vannini I; Fanini F; Fabbri M Clin Biochem; 2013 Jul; 46(10-11):918-25. PubMed ID: 23396164 [TBL] [Abstract][Full Text] [Related]
7. Clinical implication of microrna for lung cancer. Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of microRNAs in resistance to lung cancer treatments. MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062 [TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer. Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review). Liang X; Wu Q; Wang Y; Li S Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36382661 [TBL] [Abstract][Full Text] [Related]
11. MiRNA-based Therapeutics for Lung Cancer. Wu M; Wang G; Tian W; Deng Y; Xu Y Curr Pharm Des; 2018 Feb; 23(39):5989-5996. PubMed ID: 28714413 [TBL] [Abstract][Full Text] [Related]
12. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer. Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799 [TBL] [Abstract][Full Text] [Related]
13. microRNA regulation of cell viability and drug sensitivity in lung cancer. Du L; Pertsemlidis A Expert Opin Biol Ther; 2012 Sep; 12(9):1221-39. PubMed ID: 22731874 [TBL] [Abstract][Full Text] [Related]
14. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents. Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells. Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453 [TBL] [Abstract][Full Text] [Related]
16. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1. Zheng J; Xu T; Chen F; Zhang Y Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589 [TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as Therapeutic Targets for Anticancer Drugs in Lung Cancer Therapy. Liu YR; Wang PY; Xie N; Xie SY Anticancer Agents Med Chem; 2020; 20(16):1883-1894. PubMed ID: 32538735 [TBL] [Abstract][Full Text] [Related]
18. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors. Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14. Yu F; Liu JB; Wu ZJ; Xie WT; Zhong XJ; Hou LK; Wu W; Lu HM; Jiang XH; Jiang JJ; Cao ZY; Cong GJ; Shi MX; Jia CY; Lu GX; Song YC; Chai L; Lv ZW; Wu CY; Ma YS; Fu D Cancer Lett; 2018 Jul; 427():74-84. PubMed ID: 29702194 [TBL] [Abstract][Full Text] [Related]
20. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Cao L; Chen J; Ou B; Liu C; Zou Y; Chen Q Biomed Pharmacother; 2017 Sep; 93():570-579. PubMed ID: 28686971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]